| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 42.5064 | 15 |
| GSM780708 | Untreated after 4 days (C2_1) | 43.531 | 20 |
| GSM780709 | Untreated after 4 days (C3_1) | 43.7283 | 21 |
| GSM780719 | Untreated after 4 days (C1_2) | 44.1454 | 23 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.2009 | 23 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.5517 | 15 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 51.6733 | 53 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 42.4912 | 15 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.2605 | 23 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 52.021 | 54 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 41.7143 | 12 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 40.9225 | 9 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 45.2781 | 28 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.4412 | 39 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 45.5739 | 30 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.1477 | 23 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 52.1859 | 54 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 48.3682 | 43 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 40.7679 | 9 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.7724 | 36 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 46.8244 | 36 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 39.6766 | 6 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 43.3619 | 19 |